SCHEMBL25403243

SCHEMBL25403243

COc1cc(Cl)ccc1C=N[S+]([O-])C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TRPV4 Q9HBA0 1/20 0.39
MAPT P10636 6/20 0.37
KMT2A Q03164 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
GRIN2D O15399 2/20 0.34
GRIN3B O60391 2/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2A Q12879 2/20 0.34
GRIN2B Q13224 2/20 0.34
GRIN2C Q14957 2/20 0.34
GRIN3A Q8TCU5 2/20 0.34
PKM P14618 1/20 0.34
RAB9A P51151 1/20 0.34
HPGD P15428 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
AMY1A P0DUB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23522175 0.89 KMT2A (0.41) ALDH1A1GAAKDM4ETRPV4MAPT
SCHEMBL21723894 0.89 KMT2A (0.41) ALDH1A1GAAKDM4ETRPV4MAPT
SCHEMBL21723893 0.89 KMT2A (0.41) ALDH1A1GAAKDM4ETRPV4MAPT
SCHEMBL23522173 0.89 KMT2A (0.41) ALDH1A1GAAKDM4ETRPV4MAPT
SCHEMBL24838120 0.83 MEN1 (0.40) LMNAALDH1A1GAAKDM4EMAPT
SCHEMBL25602587 0.83 MEN1 (0.40) LMNAALDH1A1GAAKDM4EMAPT
SCHEMBL29792722 0.83 MEN1 (0.40) LMNAALDH1A1GAAKDM4EMAPT
SCHEMBL30594492 0.83 MEN1 (0.40) LMNAALDH1A1GAAKDM4EMAPT
SCHEMBL1888675 0.82 GRIN2D (0.44) LMNAALDH1A1GAAMAPTKMT2A
SCHEMBL1888676 0.82 GRIN2D (0.44) LMNAALDH1A1GAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516046-B2 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors MERCK SHARP & DOHME LLC (US) 2026-01-06 US disclosed
US-20230227441-A1 2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-07-20 US disclosed
CN-116056697-A 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-05-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227441-A1 2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS SCN8A, TRPV1, SCN2A LMNA 3554/4885ALDH1A1 1828/4885GAA 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.